Clinical Trial Update: A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for CagriSema assessing long-term weight loss in adults with obesity. The study is sponsored by Novo Nordisk and is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING